AtriCure, Inc. ATRC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 589.80M | 569.62M | 552.16M | 534.53M | 518.31M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 589.80M | 569.62M | 552.16M | 534.53M | 518.31M |
| Cost of Revenue | 137.18M | 135.01M | 134.70M | 133.75M | 130.24M |
| Gross Profit | 452.63M | 434.61M | 417.46M | 400.78M | 388.06M |
| SG&A Expenses | 328.33M | 323.69M | 319.51M | 311.02M | 304.86M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 572.77M | 556.73M | 555.12M | 543.98M | 544.77M |
| Operating Income | 17.04M | 12.89M | -2.97M | -9.45M | -26.46M |
| Income Before Tax | 16.20M | 12.09M | -3.26M | -10.16M | -27.83M |
| Income Tax Expenses | 1.31M | 1.54M | 1.33M | 1.29M | 947.00K |
| Earnings from Continuing Operations | 14.88 | 10.55 | -4.59 | -11.45 | -28.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.88M | 10.55M | -4.59M | -11.45M | -28.77M |
| EBIT | 17.04M | 12.89M | -2.97M | -9.45M | -26.46M |
| EBITDA | 38.20M | 33.75M | 17.75M | 11.08M | -6.21M |
| EPS Basic | 0.31 | 0.22 | -0.10 | -0.24 | -0.61 |
| Normalized Basic EPS | 0.21 | 0.16 | -0.04 | -0.13 | -0.37 |
| EPS Diluted | 0.30 | 0.21 | -0.10 | -0.25 | -0.61 |
| Normalized Diluted EPS | 0.21 | 0.15 | -0.04 | -0.13 | -0.37 |
| Average Basic Shares Outstanding | 193.85M | 192.88M | 191.93M | 190.99M | 190.16M |
| Average Diluted Shares Outstanding | 196.62M | 194.71M | 193.56M | 191.91M | 190.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |